Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials

A Coefficient of Agreement for Nominal Scales

Cohen, J. (1960) · Educational and Psychological Measurement · doi:10.1177/001316446002000104 · Cited by 42,398

Statistical Methods for Rates and Proportions

Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005

Fleiss, J. L.: Statistical Methods for Rates and Proportions. John Wiley & Sons, New York‐London‐Sydney‐Toronto 1973. XIII, 233 S.

Toutenburg, H. (1974) · Biometrische Zeitschrift · doi:10.1002/bimj.19740160814 · Cited by 1,547

The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study

Sprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., Franzini, L., Williams, A., de Haes, H. C., Hopwood, P., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2756 · Cited by 1,220

The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials

Bergman, B., Aaronson, N. K., Ahmedzai, S. H., Kaasa, S., & Sullivan, M. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90535-5 · Cited by 906

Patient versus clinician symptom reporting using the national cancer institute common terminology criteria for adverse events: results of a questionnaire-based study

Basch, E., Iasonos, A., McDonough, T., Barz, A., Culkin, A., Kris, M. G., Scher, H. I., & Schrag, D. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70910-x · Cited by 653

How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the quality-of-life questionnaire C30

Fromme, E. K., Eilers, K. M., Mori, M., Hsieh, Y.-C., & Beer, T. M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.025 · Cited by 555

Physicians' and patients' choices in evidence based practice

Haynes, R. B., Devereaux, P. J., & Guyatt, G. H. (2002) · BMJ · doi:10.1136/bmj.324.7350.1350 · Cited by 534

Correlation of patient and caregiver ratings of cancer pain

Grossman, S. A., Sheidler, V. R., Swedeen, K., Mucenski, J. W., & Piantadosi, S. (1991) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(91)90518-9 · Cited by 434

Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study)

Kreuter, M., Vansteenkiste, J., Fischer, J. R., Eberhardt, W., Zabeck, H., Kollmeier, J., Serke, M. H., Frickhofen, N., Reck, M., Engel-Riedel, W., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2015.09.014 · Cited by 34

Feasibility Assessment of Using the Complete Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Library

Shepshelovich, D., McDonald, K., Spreafico, A., Razak, A. R. A., Bedard, P. L., Siu, L. L., Minasian, L. M., & Hansen, A. R. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0332 · Cited by 33

PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients—study protocol for a randomised controlled trial

Karsten, M. M., Kühn, F., Pross, T., Blohmer, J., Hage, A. M., Fischer, F. H., Rose, M., Grittner, U., Gebert, P., Ferencz, J., et al. (2021) · Trials · doi:10.1186/s13063-021-05642-6 · Cited by 33

Incidence of Placebo Adverse Events in Randomized Clinical Trials of Targeted and Immunotherapy Cancer Drugs in the Adjuvant Setting

Chacon, M. R., Enrico, D. H., Burton, J., Waisberg, F., & Videla, V. M. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.5617 · Cited by 32

Real-World Evidence of NEPA, Netupitant-Palonosetron, in Chemotherapy-Induced Nausea and Vomiting Prevention: Effects on Quality of Life

Karthaus, M., Oskay-Özcelik, G., Wülfing, P., Hielscher, C., Guth, D., Zahn, M., Flahaut, E., & Schilling, J. (2020) · Future Oncology · doi:10.2217/fon-2020-0187 · Cited by 31

Patient-reported outcomes item selection for bladder cancer patients in chemo- or immunotherapy

Taarnhøj, G. A., Lindberg, H., Johansen, C., & Pappot, H. (2019) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-019-0141-2 · Cited by 30

Marine Invertebrate Extracts Induce Colon Cancer Cell Death via ROS-Mediated DNA Oxidative Damage and Mitochondrial Impairment

Ruiz-Torres, V., Rodríguez‐Pérez, C., Herranz‐López, M., Martín-García, B., Gómez‐Caravaca, A. M., Arraéz-Román, D., Segura‐Carretero, A., Barrajón‐Catalán, E., & Micol, V. (2019) · Biomolecules · doi:10.3390/biom9120771 · Cited by 29

Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation

Zhang, Z., Liu, J., Liu, Y., Shi, D., He, Y., & Zhao, P. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113696 · Cited by 30

The Right Dose: Results of a Patient Advocate–Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Related Side Effects and Views About Dosage Assessment to Optimize Quality of Life

Loeser, A. L., Kim, J. S., Peppercorn, J. M., Burkard, M. E., Niemierko, A., Juric, D., Kalinsky, K. M., Rugo, H. S., Glenn, L. K., Hodgdon, C., et al. (2024) · JCO Oncology Practice · doi:10.1200/op.23.00539 · Cited by 29

The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients’ quality of life

Baratelli, C., Turco, C. G. C., Lacidogna, G., Sperti, E., Vignani, F., Marino, D., Zichi, C., Luca, E. D., Audisio, M., Ballaminut, D., et al. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-04777-2 · Cited by 28

Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study

Nielsen, L. K., Stege, C. A. M., Lissenberg-Witte, B. I., van der Holt, B., Mellqvist, U., Salomo, M., Bos, G. M. J., Levin, M., Visser-Wisselaar, H. A., Hansson, M., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.222299 · Cited by 29

Case Example of Dose Optimization Using Data From Bortezomib Dose-Finding Clinical Trials

Lee, S. M., Backenroth, D., Cheung, Y. K., Hershman, D. L., Vulih, D., Anderson, B. D., Ivy, P. S., & Minasian, L. M. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.66.0662 · Cited by 29

Call to Action for Improving Oral Anticancer Agent Adherence

Levit, L. A., Arora, S., Kluetz, P. G., Magnuson, A. M., Rahman, A., & Harvey, R. D. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02529 · Cited by 30

Comparison of reporting phase I trial results in ClinicalTrials.gov and matched publications

Shepshelovich, D., Goldvaser, H., Wang, L., Razak, A. R. A., & Bedard, P. L. (2017) · Investigational New Drugs · doi:10.1007/s10637-017-0510-8 · Cited by 25

Reporting of Late Morbidity After Radiation Therapy in Large Prospective Studies: A Descriptive Review of the Current Status

Vittrup, A. S., Kirchheiner, K., Fokdal, L. U., Bentzen, S. M., Nout, R. A., Pötter, R., & Tanderup, K. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.08.040 · Cited by 28

Genomics models in radiotherapy: From mechanistic to machine learning

Kang, J., Coates, J. T. T., Strawderman, R. L., Rosenstein, B. S., & Kerns, S. L. (2020) · Medical Physics · doi:10.1002/mp.13751 · Cited by 28

Expert Consensus on Effective Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective

Vaid, A. K., Gupta, S., Doval, D., Agarwal, S., Nag, S. M., Patil, P., Goswami, C., Ostwal, V. S., Bhagat, S. B., Patil, S., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00400 · Cited by 26

Patient-Reported Outcomes and Long-Term Nonadherence to Aromatase Inhibitors

Hershman, D. L., Neugut, A. I., Moseley, A. B., Arnold, K. B., Gralow, J. R., Henry, N. L., Hillyer, G. C., Ramsey, S. D., & Unger, J. M. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab022 · Cited by 26

Patient-reported outcomes in head and neck cancer: prospective multi-institutional patient-reported toxicity

Peach, M. S., Trifiletti, D. M., Vachani, C. C., Arnold‐Korzeniowski, K., Bach, C., Hampshire, M. K., Metz, J. M., & Hill‐Kayser, C. E. (2018) · Patient Related Outcome Measures · doi:10.2147/prom.s153919 · Cited by 26

The Past, Present, and Future of Patient-Reported Outcomes in Oncology

Strong, L. E. (2015) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2015.35.e616 · Cited by 26

Characteristics of Participation in Patient-Reported Outcomes and Electronic Data Capture Components of NRG Oncology Clinical Trials

Pugh, S. L., Rodgers, J. P., Yeager, K. A., Chen, R. C., Movsas, B., Bonanni, R., Dignam, J. J., & Bruner, D. W. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.06.030 · Cited by 25

Electronic Patient Reporting of Adverse Events and Quality of Life: A Prospective Feasibility Study in General Oncology

Kennedy, F., Absolom, K. L., Clayton, B., Rogers, Z., Gordon, K., Francischetto, E. O., Blazeby, J. M., Brown, J. M., & Velikova, G. (2020) · JCO Oncology Practice · doi:10.1200/op.20.00118 · Cited by 26

Risk of Selected Dermatological Toxicities in Cancer Patients Treated with MEK Inhibitors: A Comparative Systematic Review and Meta-Analysis

Abdel-Rahman, O. M., Elhalawani, H. M., & Ahmed, H. (2015) · Future Oncology · doi:10.2217/fon.15.265 · Cited by 25

Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials – insights from an expert virtual roundtable

Yap, C., Aiyegbusi, O. L., Alger, E., Basch, E., Bell, J. A., Bhatnagar, V., Cella, D. F., Collis, P., Dueck, A. C., Gilbert, A., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102838 · Cited by 26

Clinical endpoints in trials of chemoradiation for patients with anal cancer

Glynne‐Jones, R., Adams, R., Lopes, A., & Meadows, H. M. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30190-0 · Cited by 24

Incorporating patient‐reported outcomes in dose‐finding clinical trials

Lee, S. M., Lu, X., & Cheng, B. (2019) · Statistics in Medicine · doi:10.1002/sim.8402 · Cited by 25

AMTRA: a multicentered experience of a web-based monitoring and tailored toxicity management system for cancer patients

Rasschaert, M. A., Vulsteke, C., Keersmaecker, S. D., Vandenborne, K., Dias, S., Verschaeve, V., Vuylsteke, P., Brussel, I. V., Ravelingien, J., van Dam, P. A., et al. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05550-6 · Cited by 24

Longitudinal Collection of Patient-Reported Outcomes and Activity Data during CAR-T Therapy: Feasibility, Acceptability, and Data Visualization

Oswald, L. B., Li, X., Carvajal, R., Hoogland, A. I., Gudenkauf, L. M., Hansen, D. K., Alsina, M., Locke, F. L., Rodriguez, Y., Irizarry-Arroyo, N. E., et al. (2022) · Cancers · doi:10.3390/cancers14112742 · Cited by 23

Linguistic Validation of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in Korean

Cho, J., Yoon, J., Kim, Y., Oh, D., Kim, S. J., Ahn, J., Suh, G. Y., Nam, S. J., & Mitchell, S. A. (2019) · Journal of Global Oncology · doi:10.1200/jgo.18.00193 · Cited by 23

Metoclopramide, Dexamethasone, or Palonosetron for Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting After Moderately Emetogenic Chemotherapy (MEDEA): A Randomized, Phase III, Noninferiority Trial

van der Vorst, M. J. D. L., Toffoli, E. C., Beusink, M., Linde, M. E. V., van Voorthuizen, T., Brouwer, S., van Zweeden, A. A., Vrijaldenhoven, S., Berends, J. C., Berkhof, J. H., et al. (2020) · The Oncologist · doi:10.1634/theoncologist.2020-0305 · Cited by 23

Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors: A Delphi study

Lopes, A. M. D. S., Colomer‐Lahiguera, S., Mederos, N., Aedo-Lopez, V., Spurrier‐Bernard, G., Tolstrup, L. K., Pappot, H., Aspeslagh, S., Rogiers, A., Neyns, B., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.08.026 · Cited by 23

Psychometric properties of the Canine Symptom Assessment Scale, a multidimensional owner-reported questionnaire instrument for assessment of physical symptoms in dogs with solid tumors

Giuffrida, M. A., Farrar, J. T., & Brown, D. C. (2017) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.251.12.1405 · Cited by 22

Feasibility and accessibility of electronic patient-reported outcome measures using a smartphone during routine chemotherapy: a pilot study

Bae, W. K., Kwon, J., Lee, H. W., Lee, S., Song, E., Shim, H., Ryu, K. H., Song, J.-M., Seo, S., Yang, Y., et al. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-018-4232-z · Cited by 22

Unmet needs of cancer patients with chemotherapy-related hand-foot syndrome and targeted therapy-related hand-foot skin reaction: A qualitative study

Komatsu, H., Yagasaki, K., Hirata, K., & Hamamoto, Y. (2018) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2018.12.001 · Cited by 22

Assessment of Toxic Effects Associated With Dose-Fractionated Radiotherapy Among Patients With Cancer and Comorbid Collagen Vascular Disease

Yoon, S. M., Chu, F., Ruan, D., Steinberg, M. L., Raldow, A. C., & Lee, P. P. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.34074 · Cited by 22

Impact of Patient- and Clinician-Reported Cumulative Toxicity on Quality of Life in Patients With Metastatic Castration-Naïve Prostate Cancer

Schuurhuizen, C. S. E. W., Marino, P., Braamse, A. M. J., Buffart, L. M., Joly, F., Fizazi, K. S., Habibian, M., Boher, J., Soulie, M., Oudard, S. M., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.7069 · Cited by 22

Visceral osteopathic manipulative treatment reduces patient reported digestive toxicities induced by adjuvant chemotherapy in breast cancer: A randomized controlled clinical study

Lagrange, A., Decoux, D., Briot, N., Hennequin, A., Coudert, B. P., Desmoulins, I., & Bertaut, A. (2019) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2019.08.003 · Cited by 21

Health‐related quality of life of patients with multiple myeloma: A real‐world study in China

Li, X., Liu, J., Chen, M., Gu, J., Huang, B., Zheng, D., & Li, J. (2020) · Cancer Medicine · doi:10.1002/cam4.3391 · Cited by 21

Health‐related quality‐of‐life assessment of patients with solid tumors on immuno‐oncology therapies

Voon, P. J., Cella, D. F., & Hansen, A. R. (2021) · Cancer · doi:10.1002/cncr.33457 · Cited by 21

A stakeholder-driven approach to improve the informed consent process for palliative chemotherapy

Enzinger, A. C., Wind, J. K., Frank, E., McCleary, N. J., Porter, L. D., Cushing, H., Abbott, C. H., Cronin, C. M., Enzinger, P. C., Meropol, N. J., et al. (2017) · Patient Education and Counseling · doi:10.1016/j.pec.2017.03.024 · Cited by 21

Comparison of EORTC QLQ-C30 and PRO-CTCAE™ Questionnaires on Six Symptom Items

Taarnhøj, G. A., Kennedy, F., Absolom, K. L., Bæksted, C., Vogelius, I. R., Johansen, C., Velikova, G., & Pappot, H. (2018) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2018.05.017 · Cited by 21

Integrating Patient-Reported Outcomes Into the Care of People With Advanced Cancer—A Practical Guide

Lai-Kwon, J. E., Thorner, E. D., Rutherford, C., Crossnohere, N. L., & Brundage, M. (2024) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_438512 · Cited by 21

Harnessing the Power of Patient-Reported Outcomes in Oncology

Nipp, R. D., & Temel, J. S. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0037 · Cited by 20

Long-Term Voice and Swallowing Outcomes for Oral and Oropharyngeal Cancer Following Primary or Adjuvant Chemoradiation

Soldatova, L., & Mirza, N. A. (2019) · Annals of Otology Rhinology & Laryngology · doi:10.1177/0003489419842256 · Cited by 20

Perception of side effects associated with anticancer treatment in women with breast or ovarian cancer (KEM-GO-1): a prospective trial

Ataseven, B., Frindte, J., Harter, P., Gebers, G., Vogt, C., Traut, A., Breit, E., Bluni, V., Reinisch, M., Heitz, F., et al. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-05216-y · Cited by 21

Documentation of Symptoms in Children Newly Diagnosed With Cancer Highlights the Need for Routine Assessment Using Self-report

Bradford, N., Bowers, A. P., Chan, R. J., Walker, R., Herbert, A., Cashion, C., Condon, P., & Yates, P. M. (2020) · Cancer Nursing · doi:10.1097/ncc.0000000000000849 · Cited by 20

Implementation of a cloud-based electronic patient-reported outcome (ePRO) platform in patients with advanced cancer

Generalova, O., Roy, M., Hall, E. T., Shah, S. A., Cunanan, K. M., Fardeen, T., Velazquez, B., Chu, G., Bruzzone, B., Cabot, A., et al. (2021) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-021-00358-2 · Cited by 20

Cardiac Events and Survival in Patients With EGFR-Mutant Non–Small Cell Lung Cancer Treated With Osimertinib

Lin, C., Chang, W.-T., Su, P., Kuo, C., Yang, J. C., Lin, C., & Lin, S.-H. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.48364 · Cited by 19

Using Patient-Reported Outcomes to Describe the Patient Experience on Phase I Clinical Trials

Sedhom, R., FERRELL, B. R., Ruel, N. H., Koczywas, M., Chung, V. M., & Smith, T. J. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaa067 · Cited by 19

Patient reported outcome measure domains and tools used among adolescents and young adults with cancer: A scoping review

Engstrom, T., Tanner, S., Lee, W. R., Forbes, C., Walker, R., Bradford, N., & Pole, J. D. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103867 · Cited by 19

A survey of patient and physician acceptance of skin toxicities from anti-epidermal growth factor receptor therapies

Tischer, B., Bilang, M., Kraemer, M., Ronga, P., & Lacouture, M. E. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-017-3938-7 · Cited by 19

Towards optimal stopping in radiation therapy

Ajdari, A., Niyazi, M., Nicolay, N. H., Thieke, C., Jeraj, R., & Bortfeld, T. R. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2019.01.010 · Cited by 19

Use of a Cancer Registry to Evaluate Patient-Reported Outcomes of Immune Checkpoint Inhibitors

Jim, H., Eisel, S. L., Hoogland, A. I., Shaw, S. S., King, J. C., & Dicker, A. P. (2020) · Cancers · doi:10.3390/cancers13010103 · Cited by 19

Development of patient-reported outcomes item set to evaluate acute treatment toxicity to pelvic online magnetic resonance-guided radiotherapy

Møller, P. K., Pappot, H., Bernchou, U., Schytte, T., & Dieperink, K. B. (2021) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-021-00326-w · Cited by 19

Biocompatibility and bioactivity study of a cytostatic drug belonging to the group of alkylating agents of the triazine derivative class

Mikolaichuk, O. V., Sharoyko, V. V., Popova, Е. А., Protas, A. V., Fonin, A. V., Vasina, L. V., Anufrikov, Y. A., Luttsev, M. D., Nashchekina, I. A., Malkova, A. M., et al. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.117630 · Cited by 19

The association of Health-Related Quality of Life and 1-year-survival in sarcoma patients—results of a Nationwide Observational Study (PROSa)

Eichler, M., Singer, S., Hentschel, L., Richter, S., Hohenberger, P., Kasper, B., Andreou, D., Pink, D., Jakob, J., Grützmann, R., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01702-z · Cited by 19

COMBAT study – Computer based assessment and treatment – A clinical trial evaluating impact of a computerized clinical decision support tool on pain in cancer patients

Raj, S. X., Brunelli, C., Klepstad, P., & Kaasa, S. (2017) · Scandinavian Journal of Pain · doi:10.1016/j.sjpain.2017.07.016 · Cited by 18

Impact of the Common Terminology Criteria for Adverse Events (CTCAE) evolution on toxicity scoring in gynaecological radiotherapy

Spampinato, S., Tanderup, K., Barcellini, A., Burchardt, E., Eminowicz, G., Šegedin, B., Stankiewicz, M. A., Valgma, M., & Kirchheiner, K. (2025) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2025.110881 · Cited by 18

Using Patient-Reported Outcomes in Dose-Finding Oncology Trials: Surveys of Key Stakeholders and the National Cancer Research Institute Consumer Forum

Lai-Kwon, J. E., Vanderbeek, A. M., Minchom, A. R., Aiyegbusi, O. L., Ogunleye, D., Stephens, R. J., Calvert, M., & Yap, C. (2022) · The Oncologist · doi:10.1093/oncolo/oyac117 · Cited by 17

Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702

Lee, S., Ma, C., Shi, Q., Kumar, P., Couture, F., Kuebler, P. J., Krishnamurthi, S., Lewis, D. A., Tan, B., Goldberg, R. M., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.01637 · Cited by 19

Patient-Reported Outcomes in Phase 3 Clinical Trials for Blood Cancers: A Systematic Review

Patel, K. K., Ivanov, A., Jocelyn, T., Hantel, A., Garcia, J. S., & Abel, G. A. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.14425 · Cited by 22

A systematic review of adverse event reporting in companion animal clinical trials evaluating cancer treatment

Giuffrida, M. A. (2016) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.249.9.1079 · Cited by 18

Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma

Fukushi, K., Narita, T., Hatakeyama, S., Yamamoto, H., Soma, O., Matsumoto, T., Tobisawa, Y., Yoneyama, T., Imai, A., Yoneyama, T., et al. (2016) · International Journal of Clinical Oncology · doi:10.1007/s10147-016-1071-0 · Cited by 18

Patterns of Anthracycline-Based Chemotherapy-Induced Adverse Drug Reactions and Their Impact on Relative Dose Intensity among Women with Breast Cancer in Ethiopia: A Prospective Observational Study

Gadisa, D. A., Assefa, M., Tefera, G. M., & Yimer, G. (2020) · Journal of Oncology · doi:10.1155/2020/2636514 · Cited by 21

Personalized therapy in pediatric high-risk B-cell acute lymphoblastic leukemia

Karol, S. E., & Pui, C. (2020) · Therapeutic Advances in Hematology · doi:10.1177/2040620720927575 · Cited by 18

How to implement routine electronic patient‐reported outcome monitoring in oncology rehabilitation

Wintner, L. M., Sztankay, M. J., Riedl, D., Rumpold, G., Nickels, A., Licht, T., & Holzner, B. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13694 · Cited by 19

The Value of Patient Reported Outcomes and Other Patient-Generated Health Data in Clinical Hematology

Murthy, H. S., & Wood, W. A. (2015) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-015-0261-6 · Cited by 19

Usability and User Experience of an mHealth App for Therapy Support of Patients With Breast Cancer: Mixed Methods Study Using Eye Tracking

Anders, C., Moorthy, P., Svensson, L., Müller, J., Heinze, O., Knaup, P., Wallwiener, M., Deutsch, T. M., Le, T.-V., & Weinert, L. (2024) · JMIR Human Factors · doi:10.2196/50926 · Cited by 17

Development of an electronic health record-integrated patient-reported outcome-based shared decision-making dashboard in oncology

Mohindra, N. A., Garcia, S. F., Kircher, S. M., Barnard, C., Perry, L. M., Lyleroehr, M., Coughlin, A., Morken, V., Chmiel, R., Hirschhorn, L. R., et al. (2024) · JAMIA Open · doi:10.1093/jamiaopen/ooae056 · Cited by 17

The History and Future of Multidisciplinary Cancer Care

LaVigne, A. W., Doss, V. L., Berizzi, D., Johnston, F. M., Kiess, A. P., Kirtane, K., Moghanaki, D. M., Roumeliotis, M. B., Yang, G. Q., & Viswanathan, A. N. (2024) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2024.07.006 · Cited by 17

Adverse Health Outcomes and Associations with Self-Reported General Health in Childhood Lymphoma Survivors

Jóhannsdóttir, I. M., Hamre, H. M., Fosså, S. D., Loge, J. H., Drolsum, L., Lund, M. B., Nordsletten, L., & Kiserud, C. E. (2017) · Journal of Adolescent and Young Adult Oncology · doi:10.1089/jayao.2017.0018 · Cited by 17

Rôle et utilisation des Patient reported outcomes (PROs) dans la prise en charge des patients en oncologie

Marino, P., Bannier, M., Moulin, J.-F., & Gravis, G. (2018) · Bulletin du Cancer · doi:10.1016/j.bulcan.2018.02.008 · Cited by 22

The Value of Cancer Immunotherapy Summit at the 2016 Society for Immunotherapy of Cancer 31st Anniversary Annual Meeting

Kaufman, H. L., Atkins, M. B., Dicker, A. P., Jim, H., Garrison, L. P., Herbst, R. S., McGivney, W. T., Silverstein, S., Wigginton, J. M., & Yu, P. P. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0241-6 · Cited by 17

Outcomes with multi-disciplinary management of central lung tumors with CT-guided percutaneous high dose rate brachyablation

Yoon, S. M., Suh, R. D., Abtin, F. G., Moghanaki, D. M., Genshaft, S. J., Kamrava, M. R., Drakaki, A., Liu, S. T., Venkat, P. S., Lee, A., et al. (2021) · Radiation Oncology · doi:10.1186/s13014-021-01826-1 · Cited by 16

Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials

Arenare, L., Liello, R. D., Placido, P. D., Gridelli, C., Morabito, A., Pignata, S., Nuzzo, F., Avallone, A., Maiello, E., Gargiulo, P., et al. (2024) · ESMO Open · doi:10.1016/j.esmoop.2024.102941 · Cited by 17

Chemotherapy-induced nausea and vomiting (CINV) in patients with advanced lung cancer during the first-line treatment: assessment by physicians, nurses, and patients from an Italian multicenter survey

Carnio, S., Galetta, D., Scotti, V., Cortinovis, D. L., Antonuzzo, A., Pisconti, S., Rossi, A., Martelli, O., Cecere, F. L., Lunghi, A., et al. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-017-4004-1 · Cited by 16

Clinical Relevance of Routine Monitoring of Patient-reported Outcomes Versus Clinician-reported Outcomes in Oncology

Fiteni, F., Cuenant, A., Favier, M., Cousin, C., & Houédé, N. (2018) · In Vivo · doi:10.21873/invivo.11433 · Cited by 17

Proton Beam Therapy for Head and Neck Carcinoma of Unknown Primary: Toxicity and Quality of Life

Sherry, A. D., Pasalic, D., Gunn, G. B., Fuller, C. D., Phan, J., Rosenthal, D. I., Morrison, W. H., Sturgis, E. M., Gross, N. D., Gillison, M. L., et al. (2021) · International Journal of Particle Therapy · doi:10.14338/ijpt-20-00034.1 · Cited by 16

Feasibility, usability and acceptance of weekly electronic patient-reported outcomes among patients receiving pelvic CT- or online MR-guided radiotherapy – A prospective pilot study

Møller, P. K., Pappot, H., Bernchou, U., Schytte, T., Mortensen, Z. V., Brúnni, M. F. Á., & Dieperink, K. B. (2021) · Technical Innovations & Patient Support in Radiation Oncology · doi:10.1016/j.tipsro.2021.12.001 · Cited by 16

Patient Reported Outcomes in Optimizing Myeloma Patients' Health-Related Quality of Life

King, T., King, M., & White, K. (2017) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2017.05.006 · Cited by 16

Clinical effects of assessing electronic patient-reported outcomes monitoring symptomatic toxicities during breast cancer therapy: a nationwide and population-based study

Pappot, H., Bæksted, C., Nissen, A., Knoop, A. S., Mitchell, S. A., Christensen, J., Hjøllund, N. H., & Johansen, C. (2021) · Breast Cancer · doi:10.1007/s12282-021-01244-x · Cited by 17

Risk of selected gastrointestinal toxicities in cancer patients treated with MEK inhibitors: a comparative systematic review and meta-analysis

Abdel-Rahman, O. M., Elhalawani, H. M., Ahmed, H., & Ellithy, M. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1087847 · Cited by 16

Adverse event reporting in oncology clinical trials - lost in translation?

Sivendran, S., & Galsky, M. D. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1175429 · Cited by 16

Cardiac Irradiation Predicts Activity Decline in Patients Receiving Concurrent Chemoradiation for Locally Advanced Lung Cancer

Paul, S., Bodner, W. R., Garg, M. K., Tang, J., & Ohri, N. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.05.042 · Cited by 15

Harnessing digital health to objectively assess cancer-related fatigue: The impact of fatigue on mobility performance

Sada, Y. H., Poursina, O., Zhou, H., Workeneh, B., Maddali, S. V., & Najafi, B. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246101 · Cited by 15

A tailored phase I-specific patient-reported outcome (PRO) survey to capture the patient experience of symptomatic adverse events

van Rensburg, H. J. J., Liu, Z., Watson, G. A., Veitch, Z. W. N., Shepshelovich, D., Spreafico, A., Razak, A. R. A., Bedard, P. L., Siu, L. L., Minasian, L. M., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02307-w · Cited by 16

The Effectiveness and Safety of Nurse-Led Auricular Acupressure on Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast Cancer

Jung, M. S., Kim, M., Sohn, E. H., & Lee, J. (2023) · Cancer Nursing · doi:10.1097/ncc.0000000000001286 · Cited by 15

The Physiology and Pharmacology of Nausea and Vomiting Induced by Anticancer Chemotherapy in Humans

Andrews, P. L. R., & Rudd, J. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-27016-6_2 · Cited by 16

The magnitude of neurotoxicity in patients with multiple myeloma and the impact of dose modifications: results from the population-based PROFILES registry

Beijers, A. J. M., Oerlemans, S., Mols, F., Eurelings, M., Minnema, M. C., Vreugdenhil, A., & van de Poll-Franse, L. V. (2017) · Annals of Hematology · doi:10.1007/s00277-017-2927-8 · Cited by 15

Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy

Gil, K. M., Pugh, S. L., Klopp, A. H., Yeung, A. R., Wenzel, L. B., Westin, S. N., Gaffney, D. K., Small, W. C., Thompson, S., Doncals, D. E., et al. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.04.682 · Cited by 15

A mixed‐methods study of cyclin‐dependent kinase 4 and 6 inhibitor symptom burden and quality of life among metastatic breast cancer patients and providers

Oswald, L. B., Arredondo, B. L., Kadono, M., Martinez‐Tyson, D., Meade, C. D., Penedo, F. J., Antoni, M. H., Soliman, H. H., Costa, R. L. B., & Jim, H. (2021) · Cancer Medicine · doi:10.1002/cam4.4055 · Cited by 15

Use of Survivorship Care Plans and Analysis of Patient-Reported Outcomes in Multinational Patients With Lung Cancer

Berman, A. T., DeCesaris, C. M., Simone, C. B., Vachani, C. C., DiLullo, G. A., Hampshire, M. K., Metz, J. M., & Hill‐Kayser, C. E. (2016) · Journal of Oncology Practice · doi:10.1200/jop.2015.008904 · Cited by 15

Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3

Vickers, M. M., Lee, C. K., Tu, D., Wheatley‐Price, P., Parulekar, W. R., Brundage, M., Moore, M. J., Au, H., O’Callaghan, C. J., Jonker, D. J., et al. (2016) · Pancreatology · doi:10.1016/j.pan.2016.08.013 · Cited by 15

Patients’ perceived tolerance of side effects in phase I cancer clinical trials: A qualitative study

Brédart, A., Bodson, S., Tourneau, C. L., Flahault, C., Bonnetain, F., Beaudeau, A., Coquan, E., Dolbeault, S., & Paolettí, X. (2016) · European Journal of Cancer Care · doi:10.1111/ecc.12596 · Cited by 15

Patient-reported symptoms possibly related to treatment with osimertinib or chemotherapy for advanced non-small cell lung cancer

Sebastian, M., Rydén, A., Walding, A., & Papadimitrakopoulou, V. A. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.05.003 · Cited by 15

Immune checkpoint inhibitors for the treatment of non-small cell lung cancer: A comparison of the regulatory approvals in Europe and the United States

Zaim, R., Redekop, K., & Groot, C. A. U. (2022) · Journal of Cancer Policy · doi:10.1016/j.jcpo.2022.100346 · Cited by 15

AI-Generated Content in Cancer Symptom Management: A Comparative Analysis Between ChatGPT and NCCN

Lazris, D., Schenker, Y., & Thomas, T. H. (2024) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2024.06.019 · Cited by 14

Phase II prospective trial “Give Me Five” short-term high precision radiotherapy for early prostate cancer with simultaneous boost to the dominant intraprostatic lesion: the impact of toxicity on quality of life (AIRC IG-13218)

Marvaso, G., Gugliandolo, S. G., Bellerba, F., Gandini, S., Corrao, G., Volpe, S., Rojas, D. P., Riva, G., Zerini, D., Pepa, M., et al. (2020) · Medical Oncology · doi:10.1007/s12032-020-01397-3 · Cited by 14

Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma

Fukushi, K., Narita, T., Hatakeyama, S., Yamamoto, H., Tobisawa, Y., Yoneyama, T., Yoneyama, T., Hashimoto, Y., Koie, T., & Οhyama, C. (2017) · International Journal of Urology · doi:10.1111/iju.13318 · Cited by 14

How should we assess patient-reported outcomes in the onco-hematology clinic?

Cannella, L., Efficace, F., & Giesinger, J. M. (2018) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000386 · Cited by 14

Symptomatic Toxicities Experienced During Anti-Cancer Treatment: Comparison of Patients' and Physicians' Reporting in Three Randomized Controlled Trials (Rcts)

Maïo, M. D., Piccirillo, M. C., Daniele, G., Nuzzo, F., Gridelli, C., Gebbia, V., Ciardiello, F., Placido, S. D., Ceribelli, A., Favaretto, A. G., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu356.2 · Cited by 1

Doctors less likely than patients to report toxicity of cancer treatments, study shows

Mayor, S. (2015) · BMJ · doi:10.1136/bmj.h485 · Cited by 1

Under-reporting of subjective symptoms and its prognostic value. A pooled analysis of 12 cancer clinical trials.

Arenare, L., Liello, R. D., Placido, P. D., Gridelli, C., Morabito, A., Pignata, S., Nuzzo, F., Avallone, A., Maiello, E., Gargiulo, P., et al. (2023) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.8309691

Patients’ self-assessment versus investigators’ evaluation in a phase III trial in non-castrate metastatic prostate cancer (GETUG-AFU 15)

Gravis, G., Marino, P., Joly, F., Oudard, S. M., Priou, F., Esterni, B., Latorzeff, I., Delva, R., Krakowski, I., Laguerre, B., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2013.11.034 · Cited by 69

Patient-reported outcomes in the evaluation of toxicity of anticancer treatments

Perrone, F., Basch, E., Bryce, J., & Maïo, M. D. (2022) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/sc1k-1404